What are the limitations of the non hdl cholesterol?

While the non hdl cholesterol is highly validated, it should not replace clinical judgment. OpiCalc provides the latest evidence-based limitations for the non hdl cholesterol to ensure safe bedside use and optimal diagnostic accuracy.

How does the non hdl cholesterol compare to other Cardiovascular scores?

The non hdl cholesterol is a gold-standard diagnostic tool. OpiCalc provides side-by-side clinical guidance to help clinicians choose the most specific evidence-based tool for their patient's presentation.

Is the non hdl cholesterol free to use?

Yes. OpiCalc provides the non hdl cholesterol completely ad-free and optimized for mobile bedside use, ensuring you can calculate medical risk swiftly and without distraction.

EVIDENCE SYNTHESIS

Clinical Reference Hub

Curated insights • How it Works • Practical Pearls • Evidence Base

CLINICAL INSIGHT

When to Use

Routinely on all adult patients undergoing lipid screening
Particularly crucial in patients with hypertriglyceridemia, diabetes mellitus, obesity, or metabolic syndrome, where standard LDL calculation is inaccurate

CLINICAL INSIGHT

How it Works

The Math

Non-HDL-C = Total Cholesterol - HDL. This elegant calculation completely bypasses the need for the Friedewald equation and the fasting state.

Why it works

Non-HDL cholesterol represents the total sum of all atherogenic apolipoprotein B (ApoB)-containing lipoproteins in the blood. This includes LDL, VLDL, IDL, Chylomicron remnants, and Lipoprotein(a). Since VLDL particles are highly atherogenic and elevated in metabolic syndrome, focusing exclusively on LDL misses a huge portion of the patient's cardiovascular risk.

CLINICAL INSIGHT

Practical Pearls

Fasting Not Required

Because total cholesterol and HDL are minimally affected by recent meals, non-HDL cholesterol can be accurately calculated from a non-fasting lipid panel, greatly improving patient convenience and compliance.

Guideline Targets

Non-HDL targets are typically 30 mg/dL (0.8 mmol/L) higher than the corresponding LDL target.
If LDL target is <100 mg/dL, Non-HDL target is <130 mg/dL.
If LDL target is <70 mg/dL (very high risk), Non-HDL target is <100 mg/dL.
Discordance: If LDL is at target but Non-HDL is severely elevated, the patient remains at high residual risk from triglyceride-rich lipoproteins.

CLINICAL INSIGHT

Evidence Base

Landmark Validation

Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis.

Boekholdt SM, Arsenault BJ, Mora S, et al.JAMA.2012

Clinical Reference Hub

When to Use

When to Use

How it Works

The Math

Why it works

Practical Pearls

Fasting Not Required

Guideline Targets

Evidence Base

Landmark Validation

Non-HDL Cholesterol

Clinical Reference Hub

When to Use

When to Use

How it Works

The Math

Why it works

Practical Pearls

Fasting Not Required

Guideline Targets

Evidence Base

Landmark Validation

Non-HDL Cholesterol

Clinical Evidence and Methodology

Clinical Reference Hub

When to Use

When to Use

How it Works

The Math

Why it works

Practical Pearls

Fasting Not Required

Guideline Targets

Evidence Base

Landmark Validation

Non-HDL Cholesterol

Clinical Evidence and Methodology

Clinical Reference Hub

When to Use

When to Use

How it Works

The Math

Why it works

Practical Pearls

Fasting Not Required

Guideline Targets

Evidence Base

Landmark Validation

Non-HDL Cholesterol